menu ☰
menu ˟

Addition of Farxiga to insulin, liraglutide improves glycemia in type 1 diabetes

26 May 2016
ORLANDO, Fla. — Patients with type 1 diabetes treated with insulin and liraglutide with the addition of Farxiga have significantly improvements in glycemia. Farxiga (dapagliflozin, Astra Zeneca) is an SGLT2 inhibitor that blocks the reabsorption of...

Click here to view the full article which appeared in Nursing

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.